ArticleThe Journal of clinical investigation2023

CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.

Shengnan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.